Yahoo Web Search

Search results

  1. 5 days ago · Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.

  2. May 31, 2024 · Astellas Announces a Collaboration with YASKAWA to Create an Innovative Cell Therapy Ecosystem through the Integration of Pharmaceutical and Robotics Technologies

  3. 6 days ago · ASP-4396 overview. ASP-4396 is under development for the treatment of metastatic solid tumors with KRAS G12D mutations. The drug candidate acts by targeting KRAS G12D and is administered through intravenous route. See Also: Johnson & Johnson seeks FDA approval for Tremfya for Crohn’s disease.

  4. 5 days ago · A high-level overview of Astellas Pharma Inc. (ALPMF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

  5. Jun 18, 2024 · Astellas has become the first drugmaker to bring a claudin 18.2 (CLDN18.2) targeted therapy to regulatory approval, getting a green light in Japan for Vyloy as a treatment for stomach...

  6. Jun 18, 2024 · See the latest Astellas Pharma Inc stock price (4503:XTKS), related news, valuation, dividends and more to help you make your investing decisions.

  7. People also ask

  8. 4 days ago · Stock analysis for Astellas Pharma Inc (4503:Tokyo) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

  1. People also search for